Artesunate 120 mg Injection – TARLUS 120 Injection – Trusted First-Line Defense Against Life-Threatening Malaria
TARLUS 120 – Artesunate 120mg injection is an antimalarial and anti-parasitic agent primarily used in the treatment of malaria including malaria caused by Plasmodium falciparum. It works by interrupting the growth of the plasmodium parasite in red blood cells in the human body by generating free radicals that cause oxidative stress, damaging key proteins, membranes, and DNA of the malaria parasite.
Recommended by specialists:
✅General Physician: To manage uncomplicated Plasmodium falciparum malaria.
Key benefits of Artesunate 120 mg Injection – TARLUS 120 Injection
✅First-line treatment for the management of malaria as it reduces mortality rates as compared to quinine.
✅Rapid and targeted action in the treatment of high-risk malaria, including Plasmodium falciparum malaria.
✅Injectable form has direct administration, and provides higher bioavailability and more absorption than any other formulation.
✅Well tolerated and better safety profile as compared to other conventional antimalarial like quinine.
✅Effective against resistant strains : Effective against both chloroquine-resistant and multidrug-resistant Plasmodium falciparum strains.
✅Suitable for all age patients – adults, women, children, and in the second and third trimesters of pregnancy.
Indications
✅Severe Malaria
✅Drug resistance malaria
✅Mixed infections
✅Malaria caused by Plasmodium falciparum